MBOT
Price
$1.57
Change
-$0.12 (-7.06%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
18.57M
40 days until earnings call
RCEL
Price
$7.53
Change
-$0.28 (-3.59%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
399.48M
35 days until earnings call
Ad is loading...

MBOT vs RCEL

Header iconMBOT vs RCEL Comparison
Open Charts MBOT vs RCELBanner chart's image
Microbot Medical
Price$1.57
Change-$0.12 (-7.06%)
Volume$800
Capitalization18.57M
Avita Medical
Price$7.53
Change-$0.28 (-3.59%)
Volume$2.21K
Capitalization399.48M
MBOT vs RCEL Comparison Chart
Loading...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MBOT vs. RCEL commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBOT is a Hold and RCEL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (MBOT: $1.70 vs. RCEL: $7.81)
Brand notoriety: MBOT and RCEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MBOT: 73% vs. RCEL: 152%
Market capitalization -- MBOT: $18.57M vs. RCEL: $399.48M
MBOT [@Medical Specialties] is valued at $18.57M. RCEL’s [@Medical Specialties] market capitalization is $399.48M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBOT’s FA Score shows that 0 FA rating(s) are green whileRCEL’s FA Score has 0 green FA rating(s).

  • MBOT’s FA Score: 0 green, 5 red.
  • RCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, MBOT is a better buy in the long-term than RCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBOT’s TA Score shows that 4 TA indicator(s) are bullish while RCEL’s TA Score has 3 bullish TA indicator(s).

  • MBOT’s TA Score: 4 bullish, 4 bearish.
  • RCEL’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, MBOT is a better buy in the short-term than RCEL.

Price Growth

MBOT (@Medical Specialties) experienced а +11.84% price change this week, while RCEL (@Medical Specialties) price change was -13.22% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.32%. For the same industry, the average monthly price growth was +1.69%, and the average quarterly price growth was +1.51%.

Reported Earning Dates

MBOT is expected to report earnings on May 13, 2025.

RCEL is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Medical Specialties (-4.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCEL($399M) has a higher market cap than MBOT($18.6M). MBOT YTD gains are higher at: 51.786 vs. RCEL (-38.984). MBOT has higher annual earnings (EBITDA): -10.75M vs. RCEL (-33.54M). RCEL has more cash in the bank: 89.1M vs. MBOT (8.15M). MBOT has less debt than RCEL: MBOT (245K) vs RCEL (42.4M). RCEL has higher revenues than MBOT: RCEL (50.1M) vs MBOT (0).
MBOTRCELMBOT / RCEL
Capitalization18.6M399M5%
EBITDA-10.75M-33.54M32%
Gain YTD51.786-38.984-133%
P/E RatioN/AN/A-
Revenue050.1M-
Total Cash8.15M89.1M9%
Total Debt245K42.4M1%
FUNDAMENTALS RATINGS
MBOT vs RCEL: Fundamental Ratings
MBOT
RCEL
OUTLOOK RATING
1..100
1818
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3887
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MBOT's Valuation (57) in the Biotechnology industry is in the same range as RCEL (62) in the null industry. This means that MBOT’s stock grew similarly to RCEL’s over the last 12 months.

MBOT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RCEL (100) in the null industry. This means that MBOT’s stock grew similarly to RCEL’s over the last 12 months.

MBOT's SMR Rating (99) in the Biotechnology industry is in the same range as RCEL (100) in the null industry. This means that MBOT’s stock grew similarly to RCEL’s over the last 12 months.

MBOT's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for RCEL (87) in the null industry. This means that MBOT’s stock grew somewhat faster than RCEL’s over the last 12 months.

MBOT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RCEL (100) in the null industry. This means that MBOT’s stock grew similarly to RCEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MBOTRCEL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 17 days ago
72%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TLPH0.580.05
+10.00%
Talphera
DH2.790.15
+5.68%
Definitive Healthcare Corp
DSGN3.790.18
+5.13%
Design Therapeutics
CVI19.540.32
+1.66%
CVR Energy
TU13.99-0.38
-2.64%
Telus Corp

RCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with MRCHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then MRCHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCEL
1D Price
Change %
RCEL100%
-4.41%
MRCHF - RCEL
38%
Loosely correlated
N/A
INMD - RCEL
35%
Loosely correlated
-0.66%
TRUMY - RCEL
31%
Poorly correlated
-0.54%
BLFS - RCEL
31%
Poorly correlated
+4.16%
MBOT - RCEL
30%
Poorly correlated
+12.58%
More